Subclinical neurological involvement does not develop if Wilson's disease is treated early(278 views visite) Dubbioso R, Ranucci G, Esposito M, Di Dato F, Topa A, Quarantelli M, Matarazzo M, Santoro L, Manganelli F, Iorio R
Keywords Parole chiave: Neurological Diagnostic Techniques, Outcome, Therapy, Wilson, S Disease,
Affiliations Affiliazioni: *** IBB - CNR ***
Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Italy., Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Italy., Institute of Biostructure and Bioimaging, National Research Council (CNR), Naples, Italy., Department of Translational Medical Sciences, Section of Internal Medicine, University of Naples Federico II, Italy., Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Italy. Electronic address: riorio@unina.it.,
References Riferimenti: Ala, A., Walker, A.P., Ashkan, K., Dooley, J.S., Schilsky, M.L., Wilson's disease (2007) Lancet, 369, pp. 397-40
Kinnier Wilson, S.A., Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver (1912) Brain, 34, pp. 295-509
Brewer, G.J., Dick, R.D., Johnson, V.D., Brunberg, J.A., Kluin, K.J., Fink, J.K., Treatment of Wilson's disease with zinc: XV long-term follow-up studies (1998) J. Lab. Clin. Med., 132, pp. 264-278
Iorio, R., D'Ambrosi, M., Marcellini, M., Barbera, C., Maggiore, G., Zancan, L., Serum transaminases in children with Wilson's disease (2004) J. Pediatr. Gastroenterol. Nutr., 39, pp. 331-336
Dziezyc, K., Karliński, M., Litwin, T., Członkowska, A., Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients (2014) Eur. J. Neurol., 21, pp. 332-337
Schilsky, M.L., Long-term outcome for Wilson disease: 85% good (2014) Clin. Gastroenterol. Hepatol., 12, pp. 690-691
Bruha, R., Marecek, Z., Pospisilova, L., Nevsimalova, S., Vitek, L., Martasek, P., Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation (2011) Liver Int., 31, pp. 83-91
Ranucci, G., Di Dato, F., Spagnuolo, M.I., Vajro, P., Iorio, R., Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study (2014) Orphanet J. Rare Dis., 9, p. 41
Nicastro, E., Ranucci, G., Vajro, P., Vegnente, A., Iorio, R., Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease (2010) Hepatology, 52, pp. 1948-1956
Aggarwal, A., Aggarwal, N., Nagral, A., Jankharia, G., Bhatt, M., A novel Global Assessment Scale for Wilson's Disease (GAS for WD) (2009) Mov. Disord., 24, pp. 509-518
EASL clinical practice guidelines: Wilson's disease (2012) J. Hepatol., 56, pp. 671-685
Roberts, E.A., Schilsky, M.L., American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update (2008) Hepatology, 47, pp. 2089-2111
Di Lazzaro, V., Manganelli, F., Dileone, M., Notturno, F., Esposito, M., Capasso, M., The effects of prolonged cathodal direct current stimulation on the excitatory and inhibitory circuits of theipsilateral and contralateral motor cortex (2012) J. Neural Transm., 119, pp. 1499-1506
Dubbioso, R., Moretta, P., Manganelli, F., Fiorillo, C., Iodice, R., Trojano, L., Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy (2012) J. Neurol., 259, pp. 833-837
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression (1961) Arch. Gen. Psychiatry, 4, pp. 561-571
Cummings, J.L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D.A., Gornbein, J., The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia (1994) Neurology, 44, pp. 2308-2314
Patton, J.H., Stanford, M.S., Barratt, E.S., Factor structure of the Barratt impulsiveness scale (1995) J. Clin. Psychol., 51, pp. 768-774
Perretti, A., Pellecchia, M.T., Lanzillo, B., Campanella, G., Santoro, L., Excitatory and inhibitory mechanisms in Wilson's disease: investigation with magnetic motor cortex stimulation (2001) J. Neurol. Sci., 192, pp. 35-40
Jhunjhunwala, K., Prashanth, D.K., Netravathi, M., Nagaraju, B.C., Pal, P.K., Alterations of cortical excitability and central motor conduction time in Wilson's disease (2013) Neurosci. Lett., 553, pp. 90-94
McGee, T.P., Houston, C.M., Brickley, S.G., Copper block of extrasynaptic GABAA receptors in the mature cerebellum and striatum (2013) J. Neurosci., 33, pp. 13431-13435
Tecchio, F., Assenza, G., Zappasodi, F., Mariani, S., Salustri, C., Squitti, R., Glutamate-mediated primary somatosensory cortex excitability correlated with circulating copper and ceruloplasmin (2011) Int. J. Alzheimers Dis., 2011, p. 292593
Subclinical neurological involvement does not develop if Wilson's disease is treated early
Grünewald TG, Alonso M, Avnet S, Banito A, Burdach S, Cidre-aranaz F, Di Pompo G, Distel M, Dorado-garcia H, Garcia-castro J, González-gonzález L, Grigoriadis AE, Kasan M, Koelsche C, Krumbholz M, Lecanda F, Lemma S, Longo DL, Madrigal-esquivel C, Morales-molina Á, Musa J, Ohmura S, Ory B, Pereira-silva M, Perut F, Rodriguez R, Seeling C, Al Shaaili N, Shaabani S, Shiavone K, Sinha S, Tomazou EM, Trautmann M, Vela M, Versleijen-jonkers YM, Visgauss J, Zalacain M, Schober SJ, Lissat A, English WR, Baldini N, Heymann D * Sarcoma treatment in the era of molecular medicine(20 visite) Embo Mol Med (ISSN: 1757-4676linking), 2020 Oct 13; 12(11): e11131-N/D. Impact Factor:10.293 DettagliEsporta in BibTeXEsporta in EndNote
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(211 visite) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(406 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(427 visite) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 DettagliEsporta in BibTeXEsporta in EndNote
588 Records (514 escludendo Abstract e Conferenze). Impact factor totale: 2050.456 (1809.331 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 1997.983 (1728.665 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Gennaro Angrisano on in data Sunday 12 July 2020, 13:14:47 278 views visite. Last view on Ultima visita in data Tuesday 19 January 2021, 7:55:28